Bjarne Due LARSEN,Jens Damsgaard MIKKELSEN,Søren NEVE
申请号：
US15950413
公开号：
US20180362611A1
申请日:
2018.04.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Novel peptide agonists of GLP-1 activity useful for lowering blood glucose levels. The novel peptides comprise variants of the GLP-1 or the exendin-4 polypeptide sequence and are pharmacologically active and stable. These peptides are useful in the treatment of diseases that benefit from regulation of excess levels of blood glucose and/or regulation of gastric emptying, such as diabetes and eating disorders.
